References
1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020.
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506.
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9.
4. Wang C, Deng R, Gou L, Fu Z, Zhang X, Shao F, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters. Annals of translational medicine. 2020;8(9).
5. Tan L, Wang Q, Zhang D, Ding J, Huang Q, Tang Y-Q, et al. Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study. Signal transduction and targeted therapy. 2020;5(1):1-3.
6. BAKANLIĞI TS. COVID-19 (SARS-CoV2 ENFEKSİYONU) REHBERİ. Erişim:https://covid19bilgi saglik gov tr/depo/rehberler/COVID-19_Rehberi pdf (Erişim Tarihi: 1607 2020). 2020.
7. Yang A-P, Liu J-P, Tao W-Q, Li H-m. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. International immunopharmacology. 2020;84:106504.
8. Livingston E, Bucher K. Coronavirus disease 2019 (COVID-19) in Italy, Journal.(2020). 2020.
9. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-13.
10. Wong RS, Wu A, To K, Lee N, Lam CW, Wong C, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Bmj. 2003;326(7403):1358-62.
11. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. The Lancet Respiratory Medicine. 2020;8(4):e24.
12. Fan BE. Hematologic parameters in patients with COVID‐19 infection: a reply. American journal of hematology. 2020.
13. Xu Y, Zhang Y, Jiang F, Zheng H, Pang G, Yang L, et al. Comparison of relevant indicators of coagulation and fibrinolysis in patients with varying severity of community-acquired pneumonia. Zhonghua yi xue za zhi. 2015;95(24):1925-9.
14. Elshazli RM, Toraih EA, Elgaml A, El-Mowafy M, El-Mesery M, Amin MN, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PloS one. 2020;15(8):e0238160.
15. Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clinical Chemistry and Laboratory Medicine (CCLM). 2020;58(7):1021-8.